Literature DB >> 20970452

Functional and pathological roles of the 12- and 15-lipoxygenases.

Anca D Dobrian1, David C Lieb, Banumathi K Cole, David A Taylor-Fishwick, Swarup K Chakrabarti, Jerry L Nadler.   

Abstract

The 12/15-lipoxygenase enzymes react with fatty acids producing active lipid metabolites that are involved in a number of significant disease states. The latter include type 1 and type 2 diabetes (and associated complications), cardiovascular disease, hypertension, renal disease, and the neurological conditions Alzheimer's disease and Parkinson's disease. A number of elegant studies over the last thirty years have contributed to unraveling the role that lipoxygenases play in chronic inflammation. The development of animal models with targeted gene deletions has led to a better understanding of the role that lipoxygenases play in various conditions. Selective inhibitors of the different lipoxygenase isoforms are an active area of investigation, and will be both an important research tool and a promising therapeutic target for treating a wide spectrum of human diseases. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970452      PMCID: PMC3012140          DOI: 10.1016/j.plipres.2010.10.005

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  231 in total

1.  Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies.

Authors:  Roman Stavniichuk; Viktor R Drel; Hanna Shevalye; Igor Vareniuk; Martin J Stevens; Jerry L Nadler; Irina G Obrosova
Journal:  Free Radic Biol Med       Date:  2010-06-22       Impact factor: 7.376

2.  Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase.

Authors:  Hengxuan Yang; Jia-Min Zhuo; Jin Chu; Cinzia Chinnici; Domenico Praticò
Journal:  Biol Psychiatry       Date:  2010-06-08       Impact factor: 13.382

3.  Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.

Authors:  Ganesha Rai; Victor Kenyon; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Eric Hoobler; William Leister; Anton Simeonov; Theodore R Holman; David J Maloney
Journal:  J Med Chem       Date:  2010-10-28       Impact factor: 7.446

4.  The c.-292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective.

Authors:  Jonas Wittwer; Mathias Bayer; Armin Mosandl; Jörg Muntwyler; Martin Hersberger
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

Review 5.  Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers.

Authors:  Subhash P Khanapure; David S Garvey; David R Janero; L Gordon Letts
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

6.  Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation.

Authors:  Makoto Arita; Taisuke Ohira; Yee-Ping Sun; Siva Elangovan; Nan Chiang; Charles N Serhan
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

7.  12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human Islets.

Authors:  K Ma; C S Nunemaker; R Wu; S K Chakrabarti; D A Taylor-Fishwick; J L Nadler
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

Review 8.  Physiologic and pathophysiologic roles of lipid mediators in the kidney.

Authors:  C-M Hao; M D Breyer
Journal:  Kidney Int       Date:  2007-03-14       Impact factor: 10.612

9.  Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase.

Authors:  Benjamin H Maskrey; Alexandra Bermúdez-Fajardo; Alwena H Morgan; Esther Stewart-Jones; Vincent Dioszeghy; Graham W Taylor; Paul R S Baker; Barbara Coles; Marcus J Coffey; Hartmut Kühn; Valerie B O'Donnell
Journal:  J Biol Chem       Date:  2007-05-21       Impact factor: 5.157

Review 10.  Roles of lipid mediators in kidney injury.

Authors:  Chuan-Ming Hao; Matthew D Breyer
Journal:  Semin Nephrol       Date:  2007-05       Impact factor: 5.299

View more
  118 in total

1.  D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice.

Authors:  Mohamad Navab; Srinivasa T Reddy; G M Anantharamaiah; Greg Hough; Georgette M Buga; Jan Danciger; Alan M Fogelman
Journal:  J Lipid Res       Date:  2011-12-13       Impact factor: 5.922

Review 2.  Eicosanoids, β-cell function, and diabetes.

Authors:  Pengcheng Luo; Mong-Heng Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-03       Impact factor: 3.072

3.  Differential expression and localization of 12/15 lipoxygenases in adipose tissue in human obese subjects.

Authors:  Anca D Dobrian; David C Lieb; Qian Ma; John W Lindsay; Banumathi K Cole; Kaiwen Ma; Swarup K Chakrabarti; Norine S Kuhn; Stephen D Wohlgemuth; Mark Fontana; Jerry L Nadler
Journal:  Biochem Biophys Res Commun       Date:  2010-11-19       Impact factor: 3.575

Review 4.  Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease.

Authors:  Y Imai; A D Dobrian; J R Weaver; M J Butcher; B K Cole; E V Galkina; M A Morris; D A Taylor-Fishwick; J L Nadler
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

5.  Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical role for spinal eLOX3 hepoxilin synthase activity in inflammatory hyperalgesia.

Authors:  Ann M Gregus; Darren S Dumlao; Spencer C Wei; Paul C Norris; Laura C Catella; Flore G Meyerstein; Matthew W Buczynski; Joanne J Steinauer; Bethany L Fitzsimmons; Tony L Yaksh; Edward A Dennis
Journal:  FASEB J       Date:  2013-02-04       Impact factor: 5.191

6.  Aberrant fatty acid metabolism in skeletal muscle contributes to insulin resistance in zinc transporter 7 (znt7)-knockout mice.

Authors:  Liping Huang; Surapun Tepaamorndech; Catherine P Kirschke; John W Newman; William R Keyes; Theresa L Pedersen; Jureeporn Dumnil
Journal:  J Biol Chem       Date:  2018-03-19       Impact factor: 5.157

7.  Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells.

Authors:  Suzanne E Barbour; Phuong T Nguyen; Margaret Park; Bhargavi Emani; Xiaoyong Lei; Mamatha Kambalapalli; Jacqueline C Shultz; Dayanjan Wijesinghe; Charles E Chalfant; Sasanka Ramanadham
Journal:  J Biol Chem       Date:  2015-03-11       Impact factor: 5.157

Review 8.  Bioactive lipids and pathological retinal angiogenesis.

Authors:  Khaled Elmasry; Ahmed S Ibrahim; Samer Abdulmoneim; Mohamed Al-Shabrawey
Journal:  Br J Pharmacol       Date:  2018-11-19       Impact factor: 8.739

Review 9.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

10.  Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy.

Authors:  Hang Yuan; Marpadga A Reddy; Supriya Deshpande; Ye Jia; Jung Tak Park; Linda L Lanting; Wen Jin; Mitsuo Kato; Zhong Gao Xu; Sadhan Das; Rama Natarajan
Journal:  Antioxid Redox Signal       Date:  2015-11-30       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.